LGF
TMO icon

LGT Group Foundation’s Thermo Fisher Scientific TMO Stock Holding History

LGT Group Foundation’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
3,126
-5,738
-65% -$3.11M 0.02% 174
2025
Q4 		$5.17M Buy
8,864
+248
+3% +$140K 0.06% 132
2025
Q3 		$4.57M Sell
8,616
-220
-2% -$102K 0.05% 137
2025
Q2 		$3.58M Buy
8,836
+5,669
+179% +$2.37M 0.04% 148
2025
Q1 		$1.58M Sell
3,167
-221
-7% -$120K 0.02% 183
2024
Q4 		$1.76M Sell
3,388
-760
-18% -$418K 0.03% 176
2024
Q3 		$2.51M Buy
4,148
+459
+12% +$272K 0.04% 171
2024
Q2 		$2.04M Buy
3,689
+510
+16% +$292K 0.03% 174
2024
Q1 		$1.85M Buy
3,179
+260
+9% +$146K 0.04% 172
2023
Q4 		$1.56M Sell
2,919
-12,286
-81% -$5.95M 0.03% 190
2023
Q3 		$7.54M Sell
15,205
-369
-2% -$197K 0.19% 109
2023
Q2 		$8.13M Sell
15,574
-180
-1% -$97.1K 0.2% 111
2023
Q1 		$9.08M Buy
15,754
+480
+3% +$271K 0.26% 92
2022
Q4 		$8.41M Buy
15,274
+6,793
+80% +$3.6M 0.26% 94
2022
Q3 		$4.3M Sell
8,481
-5,984
-41% -$3.35M 0.17% 112
2022
Q2 		$7.86M Buy
14,465
+10,039
+227% +$5.53M 0.24% 95
2022
Q1 		$2.62M Hold
4,426
– – 0.06% 179
2021
Q4 		$2.95M Buy
+4,426
New +$2.76M 0.08% 160

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LGT Group Foundation's TMO Position: Q1 2026 in Review

LGT Group Foundation reduced its Thermo Fisher Scientific (TMO) stake by 65% in Q1 2026, selling an estimated $3.11M and leaving 3,126 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #174.

LGT Group Foundation first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.08M in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • LGT Group Foundation held 3,126 shares of Thermo Fisher Scientific worth $1.54M as of Q1 2026.
  • LGT Group Foundation sold 5,738 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.11M.
  • Thermo Fisher Scientific made up 0.02% of LGT Group Foundation's portfolio in Q1 2026, its #174 holding.
  • LGT Group Foundation first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • LGT Group Foundation's Thermo Fisher Scientific position peaked at $9.08M in Q1 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.